PYRITHIONE ZINC

PYRITHIONE ZINC was reported 608 times

PYRITHIONE ZINC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ECZEMA COXSACKIUM 1 0.5000
1 NAEVUS SPILUS 1 0.1111
2 PERIPROCTITIS 2 0.0625
3 SEVERE MYOCLONIC EPILEPSY OF INFANCY 1 0.0323
4 LARYNGEAL ERYTHEMA 1 0.0204
5 APPLICATION SITE ALOPECIA 1 0.0182
6 SLEEP STUDY ABNORMAL 1 0.0175
7 TYMPANIC MEMBRANE HYPERAEMIA 1 0.0141
8 SPINAL CORD INJURY THORACIC 1 0.0119
9 APPLICATION SITE HYPERAESTHESIA 1 0.0101
10 PARAINFLUENZA VIRUS INFECTION 1 0.0097
11 OVERGROWTH FUNGAL 1 0.0097
12 POIKILODERMA 1 0.0093
13 HYPERTROPHIC SCAR 1 0.0092
14 METASTATIC UTERINE CANCER 1 0.0085
15 MULTIPLE CHEMICAL SENSITIVITY 1 0.0075
16 CONTRAINDICATION TO VACCINATION 1 0.0052
17 MONONEUROPATHY 1 0.0048
18 COLD URTICARIA 1 0.0045
19 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
20 NAIL BED INFECTION 1 0.0042
21 APPLICATION SITE BLEEDING 1 0.0040
22 EYELID CYST 1 0.0039
23 PARAPSORIASIS 1 0.0037
24 PANCREATIC DUCT DILATATION 1 0.0036
25 ECZEMA EYELIDS 2 0.0036
26 EAR INFLAMMATION 1 0.0035
27 MALABSORPTION FROM INJECTION SITE 1 0.0032
28 FEMORAL ARTERY OCCLUSION 1 0.0032
29 PERIORAL DERMATITIS 2 0.0031
30 RIGHT VENTRICULAR ENLARGEMENT 1 0.0031
31 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
32 ECTROPION 1 0.0030
33 CHOLURIA 1 0.0029
34 PERIORBITAL IRRITATION 1 0.0029
35 CHRONIC RESPIRATORY DISEASE 1 0.0028
36 APPLICATION SITE PUSTULES 1 0.0027
37 ERYTHROMELALGIA 1 0.0027
38 FEEDING TUBE USER 1 0.0027
39 KERATOCONUS 1 0.0027
40 NASAL TURBINATE HYPERTROPHY 1 0.0027
41 EYELID SKIN DRYNESS 3 0.0025
42 HIGH FREQUENCY ABLATION 1 0.0025
43 COLLAPSE OF LUNG 2 0.0024
44 CANDIDA TEST POSITIVE 1 0.0024
45 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
46 REFLUX LARYNGITIS 1 0.0023
47 DIVORCED 1 0.0023
48 INFUSION SITE SCAR 1 0.0023
49 DEGENERATIVE BONE DISEASE 1 0.0023
50 BANKRUPTCY 1 0.0022
51 ECZEMA HERPETICUM 1 0.0022
52 PYOGENIC GRANULOMA 1 0.0021
53 APPLICATION SITE ACNE 1 0.0020
54 DRAINAGE 1 0.0020
55 TONGUE ERUPTION 1 0.0020
56 ORBITAL OEDEMA 1 0.0020
57 CAPILLARY FRAGILITY 1 0.0020
58 HYPERMETABOLISM 1 0.0019
59 DANDRUFF 4 0.0018
60 HYPERTENSIVE URGENCY 1 0.0018
61 NAIL DYSTROPHY 1 0.0018
62 SOFT TISSUE SWELLING 1 0.0018
63 TONGUE HAEMORRHAGE 2 0.0017
64 SKIN WEEPING 6 0.0017
65 FAT NECROSIS 1 0.0016
66 ALLERGY TO METALS 1 0.0016
67 ELBOW OPERATION 1 0.0016
68 ENTEROCOCCUS TEST POSITIVE 1 0.0015
69 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
70 PRECANCEROUS CONDITION 1 0.0015
71 REBOUND ECZEMA 3 0.0015
72 ANGULAR CHEILITIS 1 0.0014
73 APPLICATION SITE ULCER 1 0.0014
74 ATROPHIC VULVOVAGINITIS 1 0.0014
75 CONTRAINDICATION TO MEDICAL TREATMENT 2 0.0013
76 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
77 POLYCYSTIC OVARIES 2 0.0013
78 INFECTION PARASITIC 1 0.0013
79 BARRETT'S OESOPHAGUS 1 0.0012
80 EXCESSIVE GRANULATION TISSUE 1 0.0012
81 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
82 VACCINATION COMPLICATION 1 0.0012
83 DERMAL CYST 3 0.0012
84 GUTTATE PSORIASIS 1 0.0012
85 TONGUE ERYTHEMA 1 0.0012
86 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
87 COVID-19 IMMUNISATION 1 0.0012
88 CATHETER SITE PAIN 3 0.0012
89 GENITAL BURNING SENSATION 1 0.0012
90 LACK OF INJECTION SITE ROTATION 2 0.0011
91 SKIN FISSURES 22 0.0011
92 SOFT TISSUE INFECTION 2 0.0011
93 BONE CONTUSION 1 0.0011
94 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
95 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
96 APPLICATION SITE SWELLING 5 0.0010
97 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
98 CONJUNCTIVAL OEDEMA 1 0.0010
99 URETEROLITHIASIS 1 0.0010
100 SKIN SWELLING 8 0.0009
101 BLADDER DILATATION 1 0.0009
102 PRODUCT NAME CONFUSION 1 0.0009
103 GRIP STRENGTH DECREASED 8 0.0009
104 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
105 LIGAMENT INJURY 1 0.0009
106 MOANING 1 0.0009
107 CEREBRAL VENTRICLE DILATATION 1 0.0009
108 CHEMICAL BURN 1 0.0009
109 HAEMANGIOMA 2 0.0009
110 OSTEOCHONDROSIS 1 0.0009
111 SINUS PAIN 2 0.0009
112 OTITIS EXTERNA 1 0.0008
113 HELICOBACTER GASTRITIS 1 0.0008
114 EYELID IRRITATION 2 0.0008
115 APPLICATION SITE PARAESTHESIA 1 0.0008
116 SCRATCH 8 0.0008
117 GASTROENTERITIS NOROVIRUS 1 0.0008
118 LIP EXFOLIATION 1 0.0008
119 SKIN HAEMORRHAGE 11 0.0007
120 SKIN DISCOMFORT 2 0.0007
121 DERMATITIS ATOPIC 39 0.0007
122 STENOTROPHOMONAS INFECTION 1 0.0007
123 IMMUNOGLOBULINS DECREASED 1 0.0007
124 APPLICATION SITE INFLAMMATION 1 0.0007
125 SKIN HYPERTROPHY 2 0.0007
126 TONIC CONVULSION 1 0.0007
127 SEBORRHOEIC KERATOSIS 1 0.0007
128 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
129 NORMOCYTIC ANAEMIA 1 0.0007
130 CONJUNCTIVITIS ALLERGIC 1 0.0007
131 HAIR TEXTURE ABNORMAL 9 0.0007
132 RUBBER SENSITIVITY 1 0.0007
133 ONYCHOLYSIS 1 0.0006
134 APPLICATION SITE PAIN 14 0.0006
135 METABOLIC ALKALOSIS 1 0.0006
136 STRONGYLOIDIASIS 1 0.0006
137 SHOULDER FRACTURE 1 0.0006
138 RECTAL ABSCESS 1 0.0006
139 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
140 APPLICATION SITE DRYNESS 2 0.0006
141 SKIN WOUND 1 0.0006
142 GLIOBLASTOMA 1 0.0006
143 LAZINESS 1 0.0006
144 INJECTION SITE OEDEMA 1 0.0006
145 CERVICAL SPINAL STENOSIS 1 0.0006
146 SENSITIVITY OF TEETH 1 0.0006
147 INFUSION SITE DISCHARGE 1 0.0006
148 SKIN HYPOPIGMENTATION 1 0.0006
149 ERYTHEMA OF EYELID 3 0.0006
150 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
151 METAMORPHOPSIA 1 0.0005
152 LOBAR PNEUMONIA 1 0.0005
153 SKIN EXFOLIATION 45 0.0005
154 NASAL OBSTRUCTION 1 0.0005
155 PARANASAL SINUS DISCOMFORT 2 0.0005
156 PANCREATIC CYST 1 0.0005
157 NASAL SEPTUM DEVIATION 1 0.0005
158 APPLICATION SITE RASH 7 0.0005
159 HYPERAEMIA 1 0.0005
160 DEVICE RELATED SEPSIS 1 0.0005
161 DRY SKIN 66 0.0005
162 DERMATITIS PSORIASIFORM 1 0.0005
163 COMPULSIVE SHOPPING 1 0.0005
164 RENAL MASS 1 0.0005
165 ECZEMA 25 0.0005
166 CATHETER SITE ERYTHEMA 1 0.0005
167 CHAPPED LIPS 2 0.0005
168 PRODUCT PREPARATION ISSUE 3 0.0005
169 ONYCHOMYCOSIS 2 0.0005
170 PRODUCT FORMULATION ISSUE 3 0.0005
171 CALCINOSIS 1 0.0004
172 PAIN OF SKIN 12 0.0004
173 BLOOD LOSS ANAEMIA 1 0.0004
174 EYELID DISORDER 1 0.0004
175 FLAT AFFECT 1 0.0004
176 NECK SURGERY 1 0.0004
177 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
178 FEAR OF INJECTION 3 0.0004
179 EOSINOPHIL COUNT DECREASED 1 0.0004
180 LACUNAR INFARCTION 1 0.0004
181 GUILLAIN-BARRE SYNDROME 2 0.0004
182 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
183 PHARYNGEAL SWELLING 4 0.0004
184 DEVICE INFUSION ISSUE 1 0.0004
185 APPLICATION SITE IRRITATION 5 0.0004
186 DERMATOMYOSITIS 1 0.0004
187 SKIN IRRITATION 18 0.0004
188 AORTIC ARTERIOSCLEROSIS 1 0.0004
189 MENOPAUSE 1 0.0004
190 BLOOD CHLORIDE DECREASED 1 0.0004
191 EYE PRURITUS 13 0.0004
192 ACTINIC KERATOSIS 1 0.0004
193 COMPARTMENT SYNDROME 1 0.0004
194 PRODUCT ODOUR ABNORMAL 4 0.0004
195 DERMATITIS 8 0.0004
196 EXFOLIATIVE RASH 1 0.0004
197 LUNG OPACITY 1 0.0004
198 GAMBLING DISORDER 1 0.0004
199 EAR CONGESTION 1 0.0004
200 SKIN WRINKLING 1 0.0004
201 APPLICATION SITE HAEMORRHAGE 1 0.0004
202 RED BLOOD CELL COUNT INCREASED 1 0.0004
203 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
204 OXYGEN SATURATION ABNORMAL 1 0.0004
205 SCAB 4 0.0004
206 EXERCISE TOLERANCE DECREASED 2 0.0003
207 SKIN ATROPHY 2 0.0003
208 PHARYNGEAL DISORDER 1 0.0003
209 SKIN WARM 2 0.0003
210 STRABISMUS 1 0.0003
211 TOOTH DISCOLOURATION 1 0.0003
212 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
213 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
214 INJECTION SITE VESICLES 2 0.0003
215 MEDICAL DEVICE DISCOMFORT 1 0.0003
216 DIASTOLIC DYSFUNCTION 1 0.0003
217 TALIPES 1 0.0003
218 HAIR COLOUR CHANGES 4 0.0003
219 INJECTION SITE HYPERSENSITIVITY 1 0.0003
220 NASAL DRYNESS 2 0.0003
221 BREAST CANCER RECURRENT 1 0.0003
222 TESTICULAR PAIN 1 0.0003
223 PNEUMONIA VIRAL 1 0.0003
224 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
225 APPLICATION SITE ERYTHEMA 8 0.0003
226 INFUSION SITE HAEMORRHAGE 1 0.0003
227 WALKING AID USER 2 0.0003
228 OTITIS MEDIA 1 0.0003
229 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
230 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
231 LIMB DISCOMFORT 9 0.0003
232 HAIR GROWTH ABNORMAL 2 0.0003
233 EYE DISCHARGE 3 0.0003
234 EAR PRURITUS 1 0.0003
235 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
236 PRURITUS 107 0.0003
237 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
238 TENDON INJURY 1 0.0003
239 SKIN INFECTION 3 0.0003
240 THROAT CLEARING 1 0.0003
241 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
242 TONGUE OEDEMA 1 0.0003
243 PARANASAL SINUS HYPERSECRETION 1 0.0003
244 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
245 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
246 OESOPHAGEAL DISORDER 1 0.0003
247 RHINOVIRUS INFECTION 1 0.0003
248 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
249 SKIN ODOUR ABNORMAL 1 0.0003
250 NECK PAIN 14 0.0003
251 BLEPHARITIS 1 0.0002
252 RHINITIS 2 0.0002
253 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
254 PSORIATIC ARTHROPATHY 10 0.0002
255 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
256 HAIR DISORDER 2 0.0002
257 THYROID FUNCTION TEST ABNORMAL 1 0.0002
258 INFUSION SITE ERYTHEMA 2 0.0002
259 ABSCESS LIMB 1 0.0002
260 INTERVERTEBRAL DISC DISORDER 1 0.0002
261 SCAR 4 0.0002
262 DEVICE OPERATIONAL ISSUE 1 0.0002
263 HORDEOLUM 1 0.0002
264 PYELONEPHRITIS 2 0.0002
265 DIVERTICULUM INTESTINAL 1 0.0002
266 TONGUE DISCOLOURATION 1 0.0002
267 MELANOCYTIC NAEVUS 1 0.0002
268 PARONYCHIA 1 0.0002
269 VULVOVAGINAL DISCOMFORT 1 0.0002
270 WHEELCHAIR USER 1 0.0002
271 RHINITIS ALLERGIC 1 0.0002
272 DRY EYE 11 0.0002
273 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
274 ROSACEA 1 0.0002
275 FEELING OF DESPAIR 1 0.0002
276 SKIN TIGHTNESS 1 0.0002
277 SQUAMOUS CELL CARCINOMA 2 0.0002
278 BLOOD PROLACTIN INCREASED 1 0.0002
279 SEASONAL ALLERGY 3 0.0002
280 SKIN ABRASION 1 0.0002
281 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
282 BREATH SOUNDS ABNORMAL 1 0.0002
283 STAPHYLOCOCCAL SEPSIS 1 0.0002
284 RASH MACULAR 7 0.0002
285 FLUID INTAKE REDUCED 1 0.0002
286 LACRIMATION INCREASED 6 0.0002
287 THERAPEUTIC RESPONSE DECREASED 12 0.0002
288 VULVOVAGINAL PRURITUS 1 0.0002
289 DRY THROAT 2 0.0002
290 PRODUCT COLOUR ISSUE 1 0.0002
291 BASAL CELL CARCINOMA 3 0.0002
292 INJECTION SITE DISCOMFORT 2 0.0002
293 RESPIRATORY TRACT CONGESTION 3 0.0002
294 RASH ERYTHEMATOUS 9 0.0002
295 EYE SWELLING 7 0.0002
296 ANAL FISTULA 1 0.0002
297 FOOD POISONING 1 0.0002
298 PRODUCT RESIDUE PRESENT 1 0.0002
299 SKIN LACERATION 2 0.0002
300 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
301 TIC 1 0.0002
302 SKIN BURNING SENSATION 13 0.0002
303 CHOKING SENSATION 1 0.0002
304 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
305 SKIN DISORDER 6 0.0002
306 PRODUCT LEAKAGE 1 0.0002
307 OCULAR DISCOMFORT 2 0.0002
308 COLECTOMY 1 0.0002
309 PERIORBITAL SWELLING 1 0.0002
310 APPLICATION SITE PRURITUS 4 0.0002
311 GENERALISED ERYTHEMA 1 0.0002
312 DERMATITIS CONTACT 2 0.0002
313 ERYTHEMA 36 0.0002
314 MICTURITION URGENCY 2 0.0002
315 CARDIAC VALVE DISEASE 1 0.0002
316 CORONARY ARTERY BYPASS 1 0.0002
317 MOUTH SWELLING 1 0.0002
318 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
319 BLOOD CHOLESTEROL INCREASED 8 0.0002
320 HYPOVOLAEMIA 1 0.0002
321 SLEEP DISORDER 12 0.0002
322 HYPERCHLORHYDRIA 1 0.0002
323 OCULAR HYPERAEMIA 8 0.0002
324 PLATELET COUNT ABNORMAL 1 0.0002
325 CONJUNCTIVITIS 3 0.0002
326 SCOLIOSIS 1 0.0002
327 PSORIASIS 21 0.0002
328 SWELLING OF EYELID 1 0.0002
329 INFUSION SITE SWELLING 1 0.0002
330 BLEPHAROSPASM 1 0.0002
331 PHOTOPSIA 1 0.0002
332 EYE IRRITATION 9 0.0002
333 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
334 EXPOSURE VIA SKIN CONTACT 4 0.0002
335 APPLICATION SITE VESICLES 1 0.0002
336 HERPES SIMPLEX 1 0.0002
337 ORAL HERPES 3 0.0002
338 TENDON DISORDER 1 0.0002
339 ARTHRITIS 12 0.0002
340 SOMNAMBULISM 1 0.0002
341 TOOTH INFECTION 2 0.0002
342 SARS-COV-2 TEST POSITIVE 2 0.0002
343 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
344 SKIN MASS 1 0.0001
345 SINUS CONGESTION 2 0.0001
346 THROAT TIGHTNESS 4 0.0001
347 PRODUCT LABEL ISSUE 1 0.0001
348 EYE MOVEMENT DISORDER 1 0.0001
349 PRODUCT PREPARATION ERROR 3 0.0001
350 ONYCHOCLASIS 1 0.0001
351 LARGE INTESTINE POLYP 1 0.0001
352 HYPERKALAEMIA 5 0.0001
353 SKIN REACTION 2 0.0001
354 PAPULE 1 0.0001
355 THERMAL BURN 1 0.0001
356 PRURITUS GENERALISED 3 0.0001
357 PARAESTHESIA ORAL 2 0.0001
358 SWELLING FACE 9 0.0001
359 RASH 60 0.0001
360 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
361 INTENTIONAL UNDERDOSE 1 0.0001
362 MAJOR DEPRESSION 1 0.0001
363 SENSITIVE SKIN 1 0.0001
364 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
365 ARTHROPOD BITE 1 0.0001
366 SUNBURN 1 0.0001
367 HYDRONEPHROSIS 1 0.0001
368 PEMPHIGOID 1 0.0001
369 TENDON PAIN 1 0.0001
370 PRODUCT AVAILABILITY ISSUE 3 0.0001
371 ILL-DEFINED DISORDER 8 0.0001
372 LIPASE INCREASED 1 0.0001
373 DEVICE RELATED INFECTION 2 0.0001
374 FOOD ALLERGY 1 0.0001
375 CONCUSSION 1 0.0001
376 RASH PRURITIC 7 0.0001
377 PULMONARY HAEMORRHAGE 1 0.0001
378 MULTIPLE ALLERGIES 1 0.0001
379 AFFECTIVE DISORDER 1 0.0001
380 HEAD INJURY 4 0.0001
381 ILLNESS 13 0.0001
382 BLOOD ALBUMIN DECREASED 1 0.0001
383 TRICUSPID VALVE INCOMPETENCE 1 0.0001
384 CYSTITIS 4 0.0001
385 ABSCESS 2 0.0001
386 ATRIAL FLUTTER 1 0.0001
387 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
388 FRUSTRATION TOLERANCE DECREASED 1 0.0001
389 SHOCK HAEMORRHAGIC 1 0.0001
390 DECUBITUS ULCER 1 0.0001
391 EYE DISORDER 4 0.0001
392 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
393 EXPIRED PRODUCT ADMINISTERED 4 0.0001
394 VIRAL INFECTION 4 0.0001
395 SKIN PLAQUE 1 0.0001
396 HEMIPARESIS 2 0.0001
397 VITAMIN D DECREASED 1 0.0001
398 PERIPHERAL SWELLING 18 0.0001
399 PSEUDOMONAS INFECTION 1 0.0001
400 MUSCLE STRAIN 1 0.0001
401 RESPIRATORY TRACT INFECTION 3 0.0001
402 GROIN PAIN 1 0.0001
403 LYMPHOCYTE COUNT DECREASED 2 0.0001
404 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
405 LYMPHADENOPATHY 4 0.0001
406 FACIAL PAIN 1 0.0001
407 GASTROINTESTINAL INFECTION 1 0.0001
408 GASTROENTERITIS VIRAL 2 0.0001
409 OROPHARYNGEAL DISCOMFORT 1 0.0001
410 LIP DRY 1 0.0001
411 PNEUMONIA BACTERIAL 1 0.0001
412 INCREASED TENDENCY TO BRUISE 1 0.0001
413 TREATMENT FAILURE 9 0.0001
414 OVARIAN CANCER 1 0.0001
415 NERVE COMPRESSION 1 0.0001
416 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
417 BLISTER 6 0.0001
418 FLANK PAIN 1 0.0001
419 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
420 INTENTIONAL DOSE OMISSION 3 0.0001
421 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
422 EYE INFLAMMATION 1 0.0001
423 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
424 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
425 DIZZINESS POSTURAL 1 0.0001
426 EAR PAIN 2 0.0001
427 AUTOIMMUNE DISORDER 1 0.0001
428 DISABILITY 2 0.0001
429 INJECTION SITE PAIN 31 0.0001
430 SINUS DISORDER 2 0.0001
431 SALIVARY HYPERSECRETION 1 0.0001
432 BURNING SENSATION 7 0.0001
433 CELLULITIS 5 0.0001
434 EMPHYSEMA 1 0.0001
435 HYPOTHERMIA 1 0.0001
436 INJECTION SITE RASH 3 0.0001
437 INITIAL INSOMNIA 1 0.0001
438 SWOLLEN TONGUE 3 0.0001
439 PULMONARY HYPERTENSION 2 0.0001
440 HAEMORRHAGE 10 0.0001
441 KNEE ARTHROPLASTY 2 0.0001
442 EATING DISORDER 2 0.0001
443 HEREDITARY ANGIOEDEMA 1 0.0001
444 SKIN CANCER 2 0.0001
445 ALOPECIA 18 0.0001
446 INJECTION SITE SWELLING 7 0.0001
447 NERVE INJURY 1 0.0001
448 BLOOD CALCIUM DECREASED 1 0.0001
449 EYE INFECTION 1 0.0001
450 STATUS EPILEPTICUS 1 0.0001
451 HEART RATE IRREGULAR 2 0.0001
452 REBOUND EFFECT 1 0.0001
453 MITRAL VALVE INCOMPETENCE 1 0.0001
454 CHOLECYSTECTOMY 1 0.0001
455 SKIN DISCOLOURATION 4 0.0001
456 HERPES ZOSTER 5 0.0001
457 NEOPLASM 1 0.0001
458 GASTRIC HAEMORRHAGE 1 0.0001
459 MUSCLE TWITCHING 2 0.0001
460 MADAROSIS 1 0.0001
461 ELECTROLYTE IMBALANCE 1 0.0001
462 PRODUCT USE ISSUE 16 0.0001
463 NASAL CONGESTION 5 0.0001
464 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
465 PRODUCT PRESCRIBING ERROR 2 0.0001
466 ACCIDENT 1 0.0001
467 HYPERLIPIDAEMIA 1 0.0001
468 THYROID CANCER 1 0.0001
469 ADRENAL INSUFFICIENCY 1 0.0001
470 NO THERAPEUTIC RESPONSE 1 0.0001
471 DISCOMFORT 5 0.0001
472 CYTOPENIA 1 0.0001
473 ENCEPHALOPATHY 2 0.0001
474 MUSCLE SPASTICITY 1 0.0001
475 CARDIOMEGALY 1 0.0001
476 SMALL INTESTINAL OBSTRUCTION 1 0.0001
477 INJECTION SITE MASS 3 0.0001
478 TENDON RUPTURE 1 0.0001
479 HYPERCALCAEMIA 1 0.0001
480 THROMBOCYTOPENIA 9 0.0001
481 ASTHMA 9 0.0001
482 DERMATITIS ALLERGIC 1 0.0001
483 BRAIN OEDEMA 1 0.0001
484 MUSCLE ATROPHY 1 0.0001
485 ROTATOR CUFF SYNDROME 1 0.0001
486 INFUSION SITE PAIN 1 0.0001
487 URTICARIA 13 0.0001
488 ANAPHYLACTIC SHOCK 2 0.0001
489 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
490 SKIN ULCER 2 0.0001
491 RHINORRHOEA 5 0.0001
492 INJECTION SITE INDURATION 1 0.0001
493 NODULE 1 0.0001
494 PRODUCT DOSE OMISSION 5 0.0001
495 BEDRIDDEN 1 0.0001
496 IMMUNE SYSTEM DISORDER 1 0.0001
497 OROPHARYNGEAL PAIN 7 0.0001
498 EAR INFECTION 2 0.0001
499 EYE HAEMORRHAGE 1 0.0001
500 SWELLING 7 0.0001
501 COVID-19 13 0.0001
502 SKIN LESION 2 0.0001
503 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
504 CONDITION AGGRAVATED 22 0.0001
505 FEELING COLD 2 0.0001
506 HUNGER 1 0.0001
507 APHONIA 1 0.0001
508 WOUND 2 0.0001
509 MASS 1 0.0001
510 CARPAL TUNNEL SYNDROME 1 0.0001
511 BLINDNESS UNILATERAL 1 0.0001
512 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
513 SINUS TACHYCARDIA 1 0.0001
514 URINARY TRACT INFECTION 12 0.0001
515 HYPERSENSITIVITY 13 0.0001
516 PARALYSIS 1 0.0001
517 ANOSMIA 1 0.0001
518 FLUID OVERLOAD 1 0.0001
519 INTENTIONAL PRODUCT MISUSE 6 0.0001
520 DYSPHONIA 4 0.0001
521 SINUSITIS 7 0.0001
522 CATARACT 4 0.0001
523 EPISTAXIS 5 0.0001
524 ECONOMIC PROBLEM 1 0.0001
525 OSTEOPENIA 1 0.0001
526 BLOOD PRESSURE INCREASED 10 0.0001
527 INSURANCE ISSUE 1 0.0001
528 THYROID DISORDER 1 0.0001
529 MUSCULOSKELETAL CHEST PAIN 1 0.0001
530 TENDONITIS 1 0.0001
531 THERAPY PARTIAL RESPONDER 1 0.0001
532 PRODUCT USE COMPLAINT 1 0.0001
533 PNEUMOTHORAX 1 0.0001
534 ULCER 1 0.0001
535 PRODUCTIVE COUGH 3 0.0001
536 INFLUENZA 7 0.0001
537 SCIATICA 1 0.0001
538 HYPOTHYROIDISM 2 0.0001
539 METABOLIC ACIDOSIS 2 0.0001
540 BACK DISORDER 1 0.0001
541 METASTASES TO BONE 1 0.0001
542 STAPHYLOCOCCAL INFECTION 2 0.0001
543 PHOTOSENSITIVITY REACTION 1 0.0001
544 BACK PAIN 14 0.0001
545 CYTOMEGALOVIRUS INFECTION 1 0.0001
546 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
547 FACE OEDEMA 1 0.0001
548 CANDIDA INFECTION 1 0.0001
549 FLUID RETENTION 3 0.0001
550 INFLAMMATION 3 0.0001
551 PRODUCT DOSE OMISSION ISSUE 17 0.0001
552 ORTHOSTATIC HYPOTENSION 1 0.0001
553 LOCAL SWELLING 1 0.0001
554 AMENORRHOEA 1 0.0001
555 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
556 ISCHAEMIC STROKE 1 0.0001
557 THIRST 1 0.0001
558 GOUT 1 0.0001
559 PAIN 34 0.0001
560 LEUKOCYTOSIS 1 0.0001
561 TOOTHACHE 1 0.0001
562 RESTLESS LEGS SYNDROME 1 0.0001
563 BONE DISORDER 1 0.0001
564 RESPIRATORY FAILURE 4 0.0001
565 END STAGE RENAL DISEASE 1 0.0001
566 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
567 BACTERIAL INFECTION 1 0.0001
568 MIDDLE INSOMNIA 1 0.0001
569 PHOTOPHOBIA 1 0.0001
570 DYSARTHRIA 2 0.0001
571 DYSPNOEA EXERTIONAL 2 0.0001
572 BLOOD SODIUM DECREASED 1 0.0001
573 PROTEINURIA 1 0.0001
574 SLEEP APNOEA SYNDROME 1 0.0001
575 MIGRAINE 5 0.0001
576 INCREASED APPETITE 1 0.0001
577 PULMONARY FIBROSIS 1 0.0001
578 LOWER LIMB FRACTURE 1 0.0001
579 ACUTE RESPIRATORY FAILURE 1 0.0001
580 HERNIA 1 0.0001
581 PRESCRIBED OVERDOSE 1 0.0001
582 HAEMORRHOIDS 1 0.0001
583 CHOKING 1 0.0001
584 SURGERY 3 0.0001
585 HEADACHE 32 0.0001
586 PAIN IN EXTREMITY 15 0.0001
587 WHEEZING 3 0.0001
588 ARTHRALGIA 21 0.0001
589 BLOOD PRESSURE ABNORMAL 1 0.0001
590 UPPER LIMB FRACTURE 1 0.0001
591 WEIGHT DECREASED 14 0.0001
592 PRESCRIBED UNDERDOSE 1 0.0001
593 COUGH 14 0.0000
594 PRODUCT PHYSICAL ISSUE 1 0.0000
595 INTENTIONAL SELF-INJURY 1 0.0000
596 SUICIDE ATTEMPT 3 0.0000
597 TASTE DISORDER 1 0.0000
598 WEIGHT INCREASED 11 0.0000
599 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
600 LUNG NEOPLASM MALIGNANT 2 0.0000
601 RIB FRACTURE 1 0.0000
602 MOUTH ULCERATION 1 0.0000
603 IRRITABLE BOWEL SYNDROME 1 0.0000
604 LIVER FUNCTION TEST INCREASED 1 0.0000
605 POOR QUALITY SLEEP 1 0.0000
606 DEEP VEIN THROMBOSIS 3 0.0000
607 MENTAL DISORDER 2 0.0000
608 BLOOD CREATININE INCREASED 3 0.0000
609 PRODUCT PRESCRIBING ISSUE 1 0.0000
610 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
611 DRUG INEFFECTIVE 60 0.0000
612 TOOTH DISORDER 1 0.0000
613 PULMONARY OEDEMA 2 0.0000
614 ORAL PAIN 1 0.0000
615 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
616 GASTROINTESTINAL DISORDER 4 0.0000
617 RASH PAPULAR 1 0.0000
618 THROAT IRRITATION 2 0.0000
619 CHROMATURIA 1 0.0000
620 SUICIDAL IDEATION 4 0.0000
621 NEPHROLITHIASIS 2 0.0000
622 PYREXIA 15 0.0000
623 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
624 PERICARDIAL EFFUSION 1 0.0000
625 CARDIAC DISORDER 4 0.0000
626 THERAPY INTERRUPTED 3 0.0000
627 MOBILITY DECREASED 3 0.0000
628 BLOOD PRESSURE FLUCTUATION 1 0.0000
629 LUNG DISORDER 2 0.0000
630 LEUKOPENIA 2 0.0000
631 THERAPY CESSATION 2 0.0000
632 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
633 HAEMATOMA 1 0.0000
634 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
635 PARAESTHESIA 6 0.0000
636 JOINT STIFFNESS 1 0.0000
637 ANHEDONIA 1 0.0000
638 GASTRITIS 1 0.0000
639 INJECTION SITE BRUISING 3 0.0000
640 INJECTION SITE HAEMORRHAGE 3 0.0000
641 JAUNDICE 1 0.0000
642 DRY MOUTH 3 0.0000
643 PALLOR 1 0.0000
644 MOOD ALTERED 1 0.0000
645 TREATMENT NONCOMPLIANCE 2 0.0000
646 RESPIRATORY DISTRESS 1 0.0000
647 ABNORMAL DREAMS 1 0.0000
648 ANAPHYLACTIC REACTION 2 0.0000
649 DIVERTICULITIS 1 0.0000
650 ARTHROPATHY 2 0.0000
651 SEPSIS 4 0.0000
652 HAEMOPTYSIS 1 0.0000
653 RENAL IMPAIRMENT 3 0.0000
654 EYE PAIN 2 0.0000
655 MYALGIA 6 0.0000
656 FLATULENCE 2 0.0000
657 ANGINA PECTORIS 1 0.0000
658 HYPERSOMNIA 1 0.0000
659 LETHARGY 2 0.0000
660 DYSSTASIA 1 0.0000
661 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
662 BONE PAIN 2 0.0000
663 PSYCHOTIC DISORDER 1 0.0000
664 URINARY INCONTINENCE 1 0.0000
665 DYSPNOEA 19 0.0000
666 HYPOAESTHESIA 5 0.0000
667 IRRITABILITY 2 0.0000
668 BLOOD POTASSIUM DECREASED 1 0.0000
669 CORONARY ARTERY DISEASE 1 0.0000
670 VERTIGO 2 0.0000
671 ACUTE KIDNEY INJURY 5 0.0000
672 CHEST PAIN 6 0.0000
673 MALAISE 14 0.0000
674 DRUG-INDUCED LIVER INJURY 1 0.0000
675 MOVEMENT DISORDER 1 0.0000
676 DIARRHOEA 20 0.0000
677 INCORRECT DOSE ADMINISTERED 7 0.0000
678 INSOMNIA 8 0.0000
679 LIP SWELLING 1 0.0000
680 DEHYDRATION 4 0.0000
681 INJECTION SITE PRURITUS 2 0.0000
682 VOMITING 14 0.0000
683 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
684 FLUSHING 3 0.0000
685 HAEMATURIA 1 0.0000
686 VISION BLURRED 4 0.0000
687 DEVICE USE ERROR 1 0.0000
688 HYPOXIA 1 0.0000
689 ANXIETY 8 0.0000
690 CEREBRAL HAEMORRHAGE 1 0.0000
691 NAUSEA 22 0.0000
692 MYELOSUPPRESSION 1 0.0000
693 NO ADVERSE EVENT 5 0.0000
694 CONSTIPATION 6 0.0000
695 HYPERGLYCAEMIA 1 0.0000
696 PANIC ATTACK 1 0.0000
697 UNDERDOSE 2 0.0000
698 MUSCLE SPASMS 5 0.0000
699 AGITATION 2 0.0000
700 DYSURIA 1 0.0000
701 HOT FLUSH 2 0.0000
702 INTESTINAL OBSTRUCTION 1 0.0000
703 GAIT DISTURBANCE 5 0.0000
704 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
705 HOSPITALISATION 4 0.0000
706 DECREASED APPETITE 6 0.0000
707 CHILLS 3 0.0000
708 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
709 DRUG INTERACTION 4 0.0000
710 OFF LABEL USE 22 0.0000
711 CARDIAC FAILURE CONGESTIVE 2 0.0000
712 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
713 EXTRA DOSE ADMINISTERED 1 0.0000
714 DYSKINESIA 1 0.0000
715 INFLUENZA LIKE ILLNESS 2 0.0000
716 VISUAL IMPAIRMENT 3 0.0000
717 DIZZINESS 12 0.0000
718 RHABDOMYOLYSIS 1 0.0000
719 POLLAKIURIA 1 0.0000
720 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
721 CARDIO-RESPIRATORY ARREST 1 0.0000
722 ROAD TRAFFIC ACCIDENT 1 0.0000
723 ABDOMINAL DISCOMFORT 4 0.0000
724 WITHDRAWAL SYNDROME 1 0.0000
725 RENAL FAILURE ACUTE 1 0.0000
726 RECTAL HAEMORRHAGE 1 0.0000
727 HYPOACUSIS 1 0.0000
728 BALANCE DISORDER 2 0.0000
729 FATIGUE 18 0.0000
730 MUSCULOSKELETAL STIFFNESS 2 0.0000
731 ANGIOEDEMA 1 0.0000
732 THERAPY NON-RESPONDER 1 0.0000
733 PRODUCT QUALITY ISSUE 3 0.0000
734 PNEUMONIA 7 0.0000
735 RENAL DISORDER 1 0.0000
736 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
737 ARRHYTHMIA 1 0.0000
738 FALL 7 0.0000
739 NEUROPATHY PERIPHERAL 2 0.0000
740 MULTIPLE SCLEROSIS 1 0.0000
741 INFECTION 3 0.0000
742 INTERSTITIAL LUNG DISEASE 1 0.0000
743 DYSPEPSIA 2 0.0000
744 HEART RATE INCREASED 2 0.0000
745 SOMNOLENCE 4 0.0000
746 CHEST DISCOMFORT 2 0.0000
747 ABDOMINAL DISTENSION 2 0.0000
748 MUSCULOSKELETAL PAIN 1 0.0000
749 SPEECH DISORDER 1 0.0000
750 PANCREATITIS 1 0.0000
751 HYPERTENSION 4 0.0000
752 PLATELET COUNT DECREASED 2 0.0000
753 ASTHENIA 7 0.0000
754 DRUG EFFECT DECREASED 1 0.0000
755 OEDEMA 1 0.0000
756 HYPONATRAEMIA 1 0.0000
757 CONVULSION 1 0.0000
758 SEIZURE 2 0.0000
759 ABDOMINAL PAIN 4 0.0000
760 PALPITATIONS 2 0.0000
761 FEELING ABNORMAL 4 0.0000
762 JOINT SWELLING 2 0.0000
763 STOMATITIS 1 0.0000
764 PLEURAL EFFUSION 1 0.0000
765 OEDEMA PERIPHERAL 2 0.0000
766 FEELING HOT 1 0.0000
767 NASOPHARYNGITIS 3 0.0000
768 INJECTION SITE ERYTHEMA 2 0.0000
769 ANAEMIA 3 0.0000
770 LOSS OF CONSCIOUSNESS 2 0.0000
771 HYPERHIDROSIS 2 0.0000
772 AMNESIA 1 0.0000
773 BLOOD PRESSURE DECREASED 1 0.0000
774 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
775 HEPATIC ENZYME INCREASED 1 0.0000
776 ABDOMINAL PAIN UPPER 3 0.0000
777 MEMORY IMPAIRMENT 2 0.0000
778 INJECTION SITE REACTION 1 0.0000
779 DEVICE MALFUNCTION 1 0.0000
780 INJURY 1 0.0000
781 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
782 BRONCHITIS 1 0.0000
783 DYSGEUSIA 1 0.0000
784 HALLUCINATION 1 0.0000
785 ACNE 1 0.0000
786 DEPRESSION 3 0.0000
787 CHRONIC KIDNEY DISEASE 1 0.0000
788 DIABETES MELLITUS 1 0.0000
789 THROMBOSIS 1 0.0000
790 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
791 CARDIAC ARREST 1 0.0000
792 PRODUCT STORAGE ERROR 1 0.0000
793 DEVICE ISSUE 1 0.0000
794 BREAST CANCER 1 0.0000
795 DYSPHAGIA 1 0.0000
796 PULMONARY EMBOLISM 1 0.0000
797 CONTUSION 1 0.0000
798 ATRIAL FIBRILLATION 1 0.0000
799 SYNCOPE 1 0.0000
800 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
801 OVERDOSE 2 0.0000
802 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
803 RHEUMATOID ARTHRITIS 1 0.0000
804 MUSCULAR WEAKNESS 1 0.0000
805 DISEASE PROGRESSION 1 0.0000
806 RENAL FAILURE 1 0.0000
807 CONFUSIONAL STATE 1 0.0000
808 DRUG DOSE OMISSION 1 0.0000
809 TREMOR 1 0.0000
810 TOXICITY TO VARIOUS AGENTS 1 0.0000
811 CEREBROVASCULAR ACCIDENT 1 0.0000
812 MYOCARDIAL INFARCTION 1 0.0000
813 BLOOD GLUCOSE INCREASED 1 0.0000
814 HYPOTENSION 1 0.0000
815 DEATH 4 0.0000